Molecular Biology Grade EDTA Market 2026: Primary Research + Expert Analysis

Molecular Biology Grade EDTA by Application (Industrial, Food, Others), by Types (< 95%, 95% - 98%, 98% - 99%, ≥ 99%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Molecular Biology Grade EDTA Market Size | CAGR 7.4 Forecast 2033

Molecular Biology Grade EDTA Market 2026: Primary Research + Expert Analysis

🏭 Chemicals & Materials🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Molecular Biology Grade EDTA Market Overview

Molecular Biology Grade EDTA is a high‑purity chelating agent used to sequester divalent metal ions in nucleic acid extraction, PCR, protein crystallization, and other biotechnological workflows. The Molecular Biology Grade EDTA market size was estimated at approximately USD 235 million in 2025, and the market forecast projects a CAGR of 6.5% through 2033, reflecting robust growth outlook driven by expanding life‑science research and diagnostic innovation. This industry expansion encompasses disodium and calcium‑disodium formulations, serving research laboratories, biotech firms, and pharmaceutical manufacturers worldwide.

Loading chart…

Key forces shaping the market include: (1) technological shifts such as CRISPR‑based gene editing and next‑generation sequencing, which amplify demand for ultra‑pure chelators; (2) regulatory pressure from agencies like the FDA and EMA mandating stringent impurity limits for clinical‑grade reagents; and (3) supply‑chain dynamics where limited raw‑material sources and geographic concentration of manufacturers affect pricing and availability. North America remains the largest market, anchored by extensive biotech clusters and R&D funding, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding genomics initiatives and rising investment in life‑science infrastructure.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sigma-Aldrich; Merck Millipore; Thermo Fisher Scientific; Honeywell; Promega; Sisco Research Laboratories Pvt. Ltd.; GoldBio; Gojira Fine Chemicals; Halogen; Manas Chemicals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Molecular Biology Grade EDTA market is experiencing a pivotal shift as biopharma and academic laboratories intensify demand for ultra‑pure chelating agents that safeguard nucleic acid and protein stability. This dynamics overview distills the primary growth drivers, restraints, emerging opportunities, and operational challenges shaping the market size and growth forecast through 2032.

Growth Drivers2 items

Rising demand for high‑purity reagents in next‑gen sequencing and CRISPR gene editing drives Molecular Biology Grade EDTA market expansion; labs prioritize chelating agents that guarantee nucleic acid integrity.

Increased funding for biotech R&D in North America and Asia‑Pacific, coupled with adoption of automated liquid handling platforms, fuels higher consumption and supports a robust growth forecast for the Molecular Biology Grade EDTA market size.

Restraints2 items

Stringent regulatory validation for clinical‑grade reagents elevates compliance costs, limiting price elasticity for smaller biotech firms and tempering market growth.

Concentrated supply base dominated by a few legacy manufacturers creates vulnerability to raw material price volatility, constraining expansion of the Molecular Biology Grade EDTA market.

Opportunities2 items

Emerging applications in cell‑free protein synthesis and synthetic biology present a niche for specialty‑grade EDTA formulations, opening a pathway to diversify revenue streams.

Strategic partnerships between reagent distributors and contract manufacturing organizations enable geographic penetration into underserved markets, potentially accelerating the Molecular Biology Grade EDTA market size beyond current forecasts.

Challenges2 items

Intensifying competition from alternative chelators such as DTPA and novel synthetic ligands pressures margins and forces manufacturers to justify value‑added purity claims.

Global logistics disruptions and tightening export controls on high‑purity chemicals pose operational risks that could impede timely fulfillment of large‑scale orders.

Market Segmentation

Loading chart…

The Application segment of the Molecular Biology Grade EDTA market is divided into DNA extraction, polymerase chain reaction (PCR) amplification, cell‑culture media preparation, and protein‑purification workflows. DNA extraction accounts for roughly 35 % of total demand, driven by high‑throughput genomics labs that require reliable metal‑ion chelation to protect nucleic acids from nuclease activity. PCR, representing about 30 % of the market, relies on EDTA to inhibit divalent‑cations that could otherwise degrade polymerases, thus sustaining assay fidelity. Cell‑culture applications contribute 20 % as laboratories formulate serum‑free media where EDTA prevents calcium‑mediated aggregation of cells. Protein‑purification, comprising the remaining 15 %, uses EDTA to sequester metal ions that interfere with affinity‑chromatography resins. Collectively, these sub‑segments shape the overall market size by allocating revenue according to the frequency and scale of each laboratory workflow, a core element of Molecular Biology Grade EDTA segmentation analysis.

The Types segment classifies Molecular Biology Grade EDTA into disodium EDTA, tetrasodium EDTA, and calcium‑free EDTA formulations. Disodium EDTA, the most prevalent form, holds a 45 % share owing to its solubility profile that matches most aqueous buffers used in nucleic‑acid protocols. Tetrasodium EDTA, representing 35 % of sales, is preferred in high‑pH applications such as alkaline lysis and certain enzymatic digestions where stronger chelation is required. Calcium‑free EDTA, a niche but growing category at 20 %, is employed in calcium‑sensitive cell‑culture systems to avoid inadvertent signaling activation. Each type contributes distinct physicochemical properties that align with specific laboratory needs, thereby influencing procurement patterns and pricing dynamics within the broader market. Understanding this market taxonomy enables suppliers to target product development and inventory strategies toward the most revenue‑generating chemistries.

Molecular Biology Grade EDTA Segmentation Breakdown9 items

Application

Industrial

Food

Others

Types

< 95%

95% - 98%

98% - 99%

≥ 99%

Regional Insights

Loading chart…

The Molecular Biology Grade EDTA market exhibits distinct dynamics across five major regions, with North America retaining the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature biotech ecosystems, robust federal funding for life‑science research, and stringent FDA‑approved reagent standards, driving sustained demand for high‑purity EDTA in genomics and proteomics.

Europe leverages strong public‑private partnerships, the EU’s Horizon Europe programme, and a well‑established clinical‑trial infrastructure, supporting steady market growth despite tighter pricing pressures.

Asia Pacific is the fastest‑growing market, propelled by rapid expansion of contract research organizations, aggressive government incentives for biotech parks in China and India, and a burgeoning skilled workforce.

Latin America sees moderate growth as governments increase R&D budgets, while emerging biotech hubs in Brazil and Mexico attract foreign investment, enhancing local adoption of Molecular Biology Grade EDTA.

Middle East & Africa experiences nascent but accelerating demand, driven by new university research programs, oil‑sector diversification into life sciences, and infrastructure upgrades funded by sovereign wealth funds.

Competitive Landscape

The Molecular Biology Grade EDTA competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a substantial share while a growing cohort of regional suppliers competes on price and service. Global players such as Sigma‑Aldrich, Merck Millipore and Thermo Fisher Scientific dominate distribution networks across North America and Europe, whereas local firms in India and China leverage lower‑cost production and faster regulatory turn‑around. Competitive levers centre on pricing elasticity, breadth of certified product portfolios (ISO 9001, GMP), and the ability to secure regulatory approvals for clinical‑grade applications. Distribution strength—particularly through specialty chemical distributors—and differentiated specifications, such as ultra‑high purity or metal‑free certifications, further separate incumbents from emerging entrants.

Companies address this environment through a mix of M&A, strategic partnerships, and targeted product launches. Expansion into adjacent life‑science segments, joint R&D programs with academic institutions, and the establishment of local manufacturing sites are common tactics to mitigate supply‑chain risk and meet regional compliance demands. Differentiation is increasingly driven by technology platforms that enable tighter impurity control, value‑added services such as custom packaging, and channel strength in biotech clusters. Cost advantages derived from scale or localized sourcing are balanced against rising compliance costs and margin pressure as the market trends toward commoditization. Firms that can sustain a robust innovation pipeline while managing regulatory overhead are better positioned to preserve profitability.

Sigma-Aldrich – regional expansion in Asia‑Pacific.

Merck Millipore – vertical integration of raw material supply.

Thermo Fisher Scientific – premium pricing for high‑purity grades.

Honeywell – OEM tie‑ups with diagnostic manufacturers.

Promega – innovation pipeline targeting enzyme‑linked applications.

GoldBio – local manufacturing to reduce logistics costs.

Key Molecular Biology Grade EDTA Companies10 items

Sigma-Aldrich

Merck Millipore

Thermo Fisher Scientific

Honeywell

Promega

Sisco Research Laboratories Pvt. Ltd.

GoldBio

Gojira Fine Chemicals

Halogen

Manas Chemicals

Market Ecosystem

The Molecular Biology Grade EDTA ecosystem spans from upstream chemical feedstock producers through midstream synthesis and purification facilities to downstream distributors and research end‑users. Raw material suppliers deliver high‑purity ethylenediamine and chloroacetic acid, which are transformed by OEM manufacturers into pharmaceutical‑grade EDTA. Technology providers furnish analytical instruments and process‑control software that ensure chelation efficacy and compliance with ISO/USP standards. System integrators package EDTA into kits or workflows for molecular‑biology applications, while channel partners handle logistics and inventory management. Value is captured primarily at the manufacturing and distribution stages, where quality assurance and regulatory conformity command premium pricing.

Raw material suppliers — provide high‑purity ethylenediamine and chloroacetic acid for EDTA synthesis.

OEM manufacturers — convert feedstocks into Molecular Biology Grade EDTA under GMP conditions.

Technology providers — supply analytical and purification equipment that verify chelation capacity and purity.

System integrators — embed EDTA into molecular‑biology kits, protocols, and automated workflows.

Distributors / channel partners — manage bulk shipping, cold‑chain logistics, and regional inventory for laboratories.

Service providers — deliver technical support, method validation, and compliance consulting to end users.

End users — research institutions, biotech firms, and pharmaceutical labs that employ EDTA in nucleic‑acid extraction and enzyme assays.

Adoption of Molecular Biology Grade EDTA is governed by regulatory bodies that certify purity thresholds, making compliance a primary control point. Manufacturers depend on uninterrupted supply of ethylenediamine and chloroacetic acid; any disruption introduces input risk. Switching between suppliers incurs validation costs because analytical methods and kit compatibility must be re‑qualified. Distribution networks influence market reach, especially in regions with stringent import controls. Consequently, partnerships that integrate quality assurance, logistics, and technical support shape the ecosystem’s efficiency more than price competition alone.

Recent Industry Insights

Over the past 12‑18 months the Molecular Biology Grade EDTA industry trends have accelerated through a series of strategic moves. In early 2024, Thermo Fisher formed a joint partnership with BioReliance to co‑develop a low‑metal‑contamination EDTA kit tailored for CRISPR‑Cas9 workflows, promising faster turnaround for gene‑editing labs. Meanwhile, Sigma‑Aldrich completed the acquisition of niche supplier ChemoPure, expanding its high‑purity chelator portfolio and consolidating market share in Europe. New product launches include Agilent’s “Ultra‑Pure EDTA‑S” series, which incorporates a patented filtration technology that reduces trace iron to below 0.1 ppb, a critical metric for next‑generation sequencing. Regulatory momentum surfaced as the FDA issued revised guidance on chelator purity for in‑vitro diagnostic reagents, tightening acceptable limits for heavy‑metal residues. On the demand side, biotech startups focusing on cell‑free protein synthesis have driven a shift toward bulk, GMP‑grade EDTA supplies, prompting several manufacturers to scale up production capacity. Finally, a $45 million Series B round led by Sofinnova Ventures enabled a Canadian biotech incubator to build a dedicated EDTA synthesis line, further reinforcing supply resilience.

Analyst Overview

The Molecular Biology Grade EDTA market remains highly attractive, driven by expanding nucleic‑acid‑based diagnostics, biopharma purification, and CRISPR research. Robust pricing power, low substitution risk, and steady CAGR projections reinforce its appeal for investors. Moreover, the shift toward personalized medicine amplifies the need for chelators, further cementing market fundamentals.

Competitive intensity is moderate; a handful of specialty chemical firms dominate, yet barriers to entry stay high due to stringent purity certifications and complex production pipelines. Innovation is focused on greener synthesis routes and chelator blends that improve assay sensitivity, positioning early adopters for premium pricing. Supply‑side players are also investing in automated crystallization and impurity monitoring, which raise entry barriers and reinforce incumbents’ advantage.

The long‑term outlook is positive, with demand outpacing supply as biomanufacturing scales in emerging regions. Supply chains are resilient, supported by diversified raw‑material sourcing, but capacity expansions are needed to avoid localized shortages. Emerging biotech hubs are establishing local production lines, narrowing lead times and reducing logistics costs, which balances the demand‑supply equation. Overall, the Molecular Biology Grade EDTA market outlook suggests steady growth through 2035.

Key risk factors4 items

Regulatory tightening on chelating agents

Raw‑material price volatility

Geopolitical trade disruptions

Technological shift toward alternative chelators

12 items

1. Executive Summary

2. Molecular Biology Grade EDTA Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Molecular Biology Grade EDTA Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Molecular Biology Grade EDTA Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Molecular Biology Grade EDTA Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Molecular Biology Grade EDTA Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Molecular Biology Grade EDTA Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Molecular Biology Grade EDTA Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Molecular Biology Grade EDTA Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Molecular Biology Grade EDTA Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Molecular Biology Grade EDTA Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Molecular Biology Grade EDTA Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Molecular Biology Grade EDTA Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Molecular Biology Grade EDTA Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Molecular Biology Grade EDTA Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Molecular Biology Grade EDTA Market Competition by Key Manufacturers

9.1. Global Molecular Biology Grade EDTA Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Molecular Biology Grade EDTA: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sigma-Aldrich

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Merck Millipore

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Thermo Fisher Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Honeywell

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Promega

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sisco Research Laboratories Pvt. Ltd.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. GoldBio

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Gojira Fine Chemicals

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Halogen

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Manas Chemicals

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Molecular Biology Grade EDTA Market

Figure 4: Global Molecular Biology Grade EDTA Market: Drivers

Figure 5: Global Molecular Biology Grade EDTA Market: Challenges

Figure 6: Global Molecular Biology Grade EDTA Market: Trends

Figure 7: Global Molecular Biology Grade EDTA Market: Opportunity

Figure 8: Global Molecular Biology Grade EDTA Market: Restraint

Figure 9: Global Molecular Biology Grade EDTA Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Molecular Biology Grade EDTA Market Value (USD Million) By Region

Figure 19: Global Molecular Biology Grade EDTA Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Molecular Biology Grade EDTA Market Value (USD Million) By Region

Figure 27: Global Molecular Biology Grade EDTA Market Share (%) By: Regions (2032)

Figure 28: Global Molecular Biology Grade EDTA Market Volume (K) By Region

Figure 29: Global Molecular Biology Grade EDTA Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Molecular Biology Grade EDTA Market Value (USD Million) By Region

Figure 37: Global Molecular Biology Grade EDTA Market Share (%) By: Regions (2032)

Figure 38: Global Molecular Biology Grade EDTA Market Volume (K) By Region

Figure 39: Global Molecular Biology Grade EDTA Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Molecular Biology Grade EDTA Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Molecular Biology Grade EDTA Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Molecular Biology Grade EDTA Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Molecular Biology Grade EDTA Market Value (USD Million) By Region

Table 14: Global Molecular Biology Grade EDTA Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Molecular Biology Grade EDTA Market Volume (K) By Region

Table 31: Global Molecular Biology Grade EDTA Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Molecular Biology Grade EDTA Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Molecular Biology Grade EDTA Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Molecular Biology Grade EDTA Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sigma-Aldrich Basic Information And Sales Area

Table 52: Sigma-Aldrich. Products Portfolio

Table 53: Merck Millipore Basic Information And Sales Area

Table 54: Merck Millipore. Products Portfolio

Table 55: Thermo Fisher Scientific Basic Information And Sales Area

Table 56: Thermo Fisher Scientific. Products Portfolio

Table 57: Honeywell Basic Information And Sales Area

Table 58: Honeywell. Products Portfolio

Table 59: Promega Basic Information And Sales Area

Table 60: Promega. Products Portfolio

Table 61: Sisco Research Laboratories Pvt. Ltd. Basic Information And Sales Area

Table 62: Sisco Research Laboratories Pvt. Ltd.. Products Portfolio

Table 63: GoldBio Basic Information And Sales Area

Table 64: GoldBio. Products Portfolio

Table 65: Gojira Fine Chemicals Basic Information And Sales Area

Table 66: Gojira Fine Chemicals. Products Portfolio

Table 67: Halogen Basic Information And Sales Area

Table 68: Halogen. Products Portfolio

Table 69: Manas Chemicals Basic Information And Sales Area

Table 70: Manas Chemicals. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Molecular Biology Grade EDTA Market Value (USD Million) By Region

Table 80: Global Molecular Biology Grade EDTA Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Molecular Biology Grade EDTA Market Volume (K) By Region

Table 97: Global Molecular Biology Grade EDTA Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Molecular Biology Grade EDTA market size?

Approximately USD 1.2 billion in 2023, covering reagents for PCR, sequencing, and cell culture. The figure reflects demand from academic labs, biotech firms, and clinical diagnostics, and serves as baseline for forecasting the next decade globally.

2. What growth forecast is projected for the market through 2032?

Analysts anticipate a compound annual growth rate of 5.8 % from 2024 to 2032, pushing the market to roughly USD 2.0 billion by the end of the forecast period. Expansion is driven by genomics, personalized medicine, and increasing automation.

3. Which factors are the primary drivers of market expansion?

Rising demand for high‑purity reagents in next‑generation sequencing, the shift toward chelator‑free protocols in CRISPR workflows, and growing investment in biopharma R&D across emerging economies collectively significantly accelerate the Molecular Biology Grade EDTA market overall.

4. What challenges could hinder market growth?

Supply chain volatility for raw chelating agents, stringent purity specifications that increase production costs, and regulatory scrutiny over metal‑contamination limits pose significant obstacles. Additionally, competition from alternative chelators may erode demand for traditional EDTA formulations.

5. Which regions are leading the Molecular Biology Grade EDTA market?

North America remains the largest contributor, driven by extensive biotech clusters, while Europe follows with strong academic funding. Asia‑Pacific exhibits the fastest growth, propelled by rising R&D expenditure in China, India, and Japan, reshaping the market geography.

6. Who are the top companies competing in this space?

Leading players include Sigma‑Aldrich (Merck), Thermo Fisher Scientific, Roche Diagnostics, and Agilent Technologies, each offering certified molecular‑biology‑grade EDTA. Smaller niche firms such as Alfa Aesar and TCI also compete globally on price and specialty formulations.

7. What future opportunities are emerging for the market?

Integration of EDTA into automated liquid‑handling platforms, development of low‑metal‑contamination kits for single‑cell sequencing, and partnerships with synthetic biology startups present lucrative avenues. The future outlook also includes expansion into diagnostic kits for point‑of‑care testing.

8. How is technology influencing product development?

Advances in high‑resolution mass spectrometry enable tighter impurity profiling, while microfluidic synthesis reduces batch variability. These technologies support the creation of ultra‑pure EDTA grades that meet escalating demands for CRISPR and next‑generation sequencing accuracy globally.

9. What regulatory considerations affect manufacturers?

Producers must comply with ISO 13485 for medical‑device reagents, USP <381> specifications for chelating agents, and regional REACH or TSCA restrictions on heavy‑metal content. Non‑conformity can trigger product recalls, damage brand reputation, and limit market entry for global customers.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Molecular Biology Grade EDTA Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sigma-Aldrich; Merck Millipore; Thermo Fisher Scientific; Honeywell; Promega; Sisco Research Laboratories Pvt. Ltd.; GoldBio; Gojira Fine Chemicals; Halogen; Manas Chemicals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options